Clinical Outcomes of an Intensive Mother–Baby Program for Perinatal Mental Illness

Perinatal mental illness can profoundly disrupt both individual well-being and early parent–infant bonding. Severe depression, anxiety, and related conditions during pregnancy and postpartum often require intensive treatment, yet traditional models of care may separate parent and infant or fail to accommodate the relational realities of early caregiving. Interventions that simultaneously address acute psychiatric symptoms and the developing parent–infant relationship represent a critical innovation in perinatal mental health services.

In the MRI-funded project Clinical Outcomes of an Intensive Mother–Baby Program for Perinatal Mental Illness, Dr. Gretchen Buchanan (Hennepin Healthcare Research Institute) evaluates outcomes associated with the Redleaf Center for Family Healing in Minnesota. The Redleaf model is distinctive in its integration of psychiatric treatment with intentional relational support, particularly through its Mother–Baby Day Hospital, a partial hospitalization program that includes infants in treatment whenever clinically appropriate.

The study employs a retrospective cohort design examining approximately 2,000 patients who received services between 2013 and 2025. By analyzing routinely collected clinical data, the project assesses symptom trajectories and functional outcomes across multiple levels of care, including the Day Hospital, the Perinatal Outpatient Program (POP), and outpatient psychiatry and psychotherapy. The broad timeframe allows examination of service utilization and outcomes before and after COVID-related healthcare shifts.

Validated patient-reported measures serve as primary outcomes, including the Edinburgh Postnatal Depression Scale (EPDS), Generalized Anxiety Disorder-7 (GAD-7), Barkin Index of Maternal Functioning (BIMF), and the Postpartum Bonding Questionnaire (PBQ). Demographic and diagnostic data from electronic health records enable characterization of the patient population and identification of clinical predictors.

The evaluation proceeds in three analytic phases. First, descriptive analyses map changes in patient characteristics and symptom profiles over time, including potential shifts associated with the pandemic and service adaptations. Second, models examine retention and dropout, identifying demographic or clinical factors linked to non-completion of treatment. Third, outcome analyses test whether improvements observed in earlier program evaluations are sustained across the full 2013–2025 cohort and across varying levels of care.

By integrating real-world clinical data with rigorous longitudinal and person-centered analytic strategies, this project advances implementation-informed perinatal mental health research. The findings are positioned to clarify who benefits most from intensive mother–baby programming, where engagement barriers arise, and how services can be refined to strengthen both psychiatric recovery and relational well-being during a developmentally sensitive period.

Sophie Suberville